- Home
- LOW vs BMY Comparison
LOW vs BMY Comparison
Compare LOW & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LOW
- BMY
- Stock Information
- Founded
- LOW 1946
- BMY 1887
- Country
- LOW United States
- BMY United States
- Employees
- LOW N/A
- BMY N/A
- Industry
- LOW RETAIL: Building Materials
- BMY Biotechnology: Pharmaceutical Preparations
- Sector
- LOW Consumer Discretionary
- BMY Health Care
- Exchange
- LOW Nasdaq
- BMY Nasdaq
- Market Cap
- LOW 150.3B
- BMY 120.4B
- IPO Year
- LOW N/A
- BMY N/A
- Fundamental
- Price
- LOW $247.60
- BMY $57.28
- Analyst Decision
- LOW Buy
- BMY Hold
- Analyst Count
- LOW 26
- BMY 15
- Target Price
- LOW $282.23
- BMY $55.93
- AVG Volume (30 Days)
- LOW 2.5M
- BMY 10.1M
- Earning Date
- LOW 11-19-2024
- BMY 02-06-2025
- Dividend Yield
- LOW 1.86%
- BMY 4.33%
- EPS Growth
- LOW N/A
- BMY N/A
- EPS
- LOW 11.98
- BMY N/A
- Revenue
- LOW $83,722,000,000.00
- BMY $47,435,000,000.00
- Revenue This Year
- LOW N/A
- BMY $7.22
- Revenue Next Year
- LOW $1.44
- BMY $0.16
- P/E Ratio
- LOW $20.69
- BMY N/A
- Revenue Growth
- LOW N/A
- BMY 5.56
- 52 Week Low
- LOW $209.55
- BMY $39.35
- 52 Week High
- LOW $287.01
- BMY $61.08
- Technical
- Relative Strength Index (RSI)
- LOW 30.86
- BMY 50.79
- Support Level
- LOW $269.54
- BMY $55.04
- Resistance Level
- LOW $273.35
- BMY $58.55
- Average True Range (ATR)
- LOW 5.30
- BMY 1.28
- MACD
- LOW -2.81
- BMY -0.31
- Stochastic Oscillator
- LOW 9.83
- BMY 44.36
About LOW Lowe's Companies Inc.
Lowe's is the second-largest home improvement retailer in the world, operating more than 1,700 stores in the United States, after the 2023 divestiture of its Canadian locations (RONA, Lowe's Canada, Réno-Dépôt, and Dick's Lumber). The firm's stores offer products and services for home decorating, maintenance, repair, and remodeling, with maintenance and repair accounting for two thirds of products sold. Lowe's targets retail do-it-yourself (around 75% of sales) and do-it-for-me customers as well as commercial and professional business clients (around 25% of sales). We estimate Lowe's captures a high-single-digit share of the domestic home improvement market, based on US Census data and management's market size estimates.
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.